Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Summary: Retatrutide FDA Status Retatrutide is not FDA-approved and won't be for at least another year It's in Phase 3 trials (TRIUMPH program) with results expected in late 2026 FDA approval is projected for 20272028 Phase 2 data showed 24.2% weight loss , better than any approved GLP-1 medication Current access: clinical trials (free), compounded retatrutide ($200$500/mo), or research peptides ($150$500/mo) When approved, retatrutide will be the first triple-agonist obesity medication on the market References Jastreboff AM, Aronne LJ, Ahmad NN, et al
When children come in contact with it, it can drive virilization and early onset or accelerated puberty.20 26 Fortunately, Henry offers testosterone cream in concentrations as low as 1.5%, which can offset some of the risk posed by its residue
Morning fatigue that resolved with electrolyte supplementation
Prefer to talk now
Peptides are only one piece of the puzzle
The Power of Online Weight Loss Michigan The rise of telehealth has fundamentally changed how many medical services are delivered, and weight management is a prime example
